Cargando…
Bi-specific splice-switching PMO oligonucleotides conjugated via a single peptide active in a mouse model of Duchenne muscular dystrophy
The potential for therapeutic application of splice-switching oligonucleotides (SSOs) to modulate pre-mRNA splicing is increasingly evident in a number of diseases. However, the primary drawback of this approach is poor cell and in vivo oligonucleotide uptake efficacy. Biological activities can be s...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288157/ https://www.ncbi.nlm.nih.gov/pubmed/25468897 http://dx.doi.org/10.1093/nar/gku1256 |
_version_ | 1782351918823112704 |
---|---|
author | Shabanpoor, Fazel McClorey, Graham Saleh, Amer F. Järver, Peter Wood, Matthew J.A. Gait, Michael J. |
author_facet | Shabanpoor, Fazel McClorey, Graham Saleh, Amer F. Järver, Peter Wood, Matthew J.A. Gait, Michael J. |
author_sort | Shabanpoor, Fazel |
collection | PubMed |
description | The potential for therapeutic application of splice-switching oligonucleotides (SSOs) to modulate pre-mRNA splicing is increasingly evident in a number of diseases. However, the primary drawback of this approach is poor cell and in vivo oligonucleotide uptake efficacy. Biological activities can be significantly enhanced through the use of synthetically conjugated cationic cell penetrating peptides (CPPs). Studies to date have focused on the delivery of a single SSO conjugated to a CPP, but here we describe the conjugation of two phosphorodiamidate morpholino oligonucleotide (PMO) SSOs to a single CPP for simultaneous delivery and pre-mRNA targeting of two separate genes, exon 23 of the Dmd gene and exon 5 of the Acvr2b gene, in a mouse model of Duchenne muscular dystrophy. Conjugations of PMOs to a single CPP were carried out through an amide bond in one case and through a triazole linkage (‘click chemistry’) in the other. The most active bi-specific CPP–PMOs demonstrated comparable exon skipping levels for both pre-mRNA targets when compared to individual CPP–PMO conjugates both in cell culture and in vivo in the mdx mouse model. Thus, two SSOs with different target sequences conjugated to a single CPP are biologically effective and potentially suitable for future therapeutic exploitation. |
format | Online Article Text |
id | pubmed-4288157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-42881572015-02-19 Bi-specific splice-switching PMO oligonucleotides conjugated via a single peptide active in a mouse model of Duchenne muscular dystrophy Shabanpoor, Fazel McClorey, Graham Saleh, Amer F. Järver, Peter Wood, Matthew J.A. Gait, Michael J. Nucleic Acids Res Chemical Biology and Nucleic Acid Chemistry The potential for therapeutic application of splice-switching oligonucleotides (SSOs) to modulate pre-mRNA splicing is increasingly evident in a number of diseases. However, the primary drawback of this approach is poor cell and in vivo oligonucleotide uptake efficacy. Biological activities can be significantly enhanced through the use of synthetically conjugated cationic cell penetrating peptides (CPPs). Studies to date have focused on the delivery of a single SSO conjugated to a CPP, but here we describe the conjugation of two phosphorodiamidate morpholino oligonucleotide (PMO) SSOs to a single CPP for simultaneous delivery and pre-mRNA targeting of two separate genes, exon 23 of the Dmd gene and exon 5 of the Acvr2b gene, in a mouse model of Duchenne muscular dystrophy. Conjugations of PMOs to a single CPP were carried out through an amide bond in one case and through a triazole linkage (‘click chemistry’) in the other. The most active bi-specific CPP–PMOs demonstrated comparable exon skipping levels for both pre-mRNA targets when compared to individual CPP–PMO conjugates both in cell culture and in vivo in the mdx mouse model. Thus, two SSOs with different target sequences conjugated to a single CPP are biologically effective and potentially suitable for future therapeutic exploitation. Oxford University Press 2015-01-09 2014-12-02 /pmc/articles/PMC4288157/ /pubmed/25468897 http://dx.doi.org/10.1093/nar/gku1256 Text en © The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Chemical Biology and Nucleic Acid Chemistry Shabanpoor, Fazel McClorey, Graham Saleh, Amer F. Järver, Peter Wood, Matthew J.A. Gait, Michael J. Bi-specific splice-switching PMO oligonucleotides conjugated via a single peptide active in a mouse model of Duchenne muscular dystrophy |
title | Bi-specific splice-switching PMO oligonucleotides conjugated via a single peptide active in a mouse model of Duchenne muscular dystrophy |
title_full | Bi-specific splice-switching PMO oligonucleotides conjugated via a single peptide active in a mouse model of Duchenne muscular dystrophy |
title_fullStr | Bi-specific splice-switching PMO oligonucleotides conjugated via a single peptide active in a mouse model of Duchenne muscular dystrophy |
title_full_unstemmed | Bi-specific splice-switching PMO oligonucleotides conjugated via a single peptide active in a mouse model of Duchenne muscular dystrophy |
title_short | Bi-specific splice-switching PMO oligonucleotides conjugated via a single peptide active in a mouse model of Duchenne muscular dystrophy |
title_sort | bi-specific splice-switching pmo oligonucleotides conjugated via a single peptide active in a mouse model of duchenne muscular dystrophy |
topic | Chemical Biology and Nucleic Acid Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288157/ https://www.ncbi.nlm.nih.gov/pubmed/25468897 http://dx.doi.org/10.1093/nar/gku1256 |
work_keys_str_mv | AT shabanpoorfazel bispecificspliceswitchingpmooligonucleotidesconjugatedviaasinglepeptideactiveinamousemodelofduchennemusculardystrophy AT mccloreygraham bispecificspliceswitchingpmooligonucleotidesconjugatedviaasinglepeptideactiveinamousemodelofduchennemusculardystrophy AT salehamerf bispecificspliceswitchingpmooligonucleotidesconjugatedviaasinglepeptideactiveinamousemodelofduchennemusculardystrophy AT jarverpeter bispecificspliceswitchingpmooligonucleotidesconjugatedviaasinglepeptideactiveinamousemodelofduchennemusculardystrophy AT woodmatthewja bispecificspliceswitchingpmooligonucleotidesconjugatedviaasinglepeptideactiveinamousemodelofduchennemusculardystrophy AT gaitmichaelj bispecificspliceswitchingpmooligonucleotidesconjugatedviaasinglepeptideactiveinamousemodelofduchennemusculardystrophy |